|
Novartis prepares for looming loss of diovan patent
MarketWatch - … prepare for the expected loss of revenue when the patent of its best-selling drug Diovan will expire in four years, the Swiss drugmaker said Wednesday. … Novartis to Focus on Biologic Drugs as Generics Loom (Update1) UPDATE 2-US asks for more data on Novartis cancer drug Novartis to Combine Heart Pills as Afinitor Cancer Drug Delayed |
More: continued here
If you like this post, please buy me a beer for $3 8-)
Blogsphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg
RSS feed for comments on this post | TrackBack URI for this post
Best Deal Ads :
Leave a Reply
Resources
Blog Categories
Monthly Archives
By Month
- December 2008 (94)
- November 2008 (79)
- October 2008 (91)
- September 2008 (78)
- August 2008 (77)
- July 2008 (43)
- June 2008 (62)
Recent Comments:
Recent Trackbacks:
